1 June 1999 in Hepatology
Insulin and insulin–like growth factor (IGF–1) are mitogenic for fibroblasts and smooth muscle cells. IGF–1 increases in inflamed and fibrotic tissues and induces proliferation of rat hepatic stellate cells (HSC). This study evaluates the potential roles of these hormones in the development of liver fibrosis. Insulin and IGF–1 receptor expression was evaluated by immunohistochemistry in both cultured human HSC and human liver tissue. Phosphorylation of both 70–kd S6 kinase and extracellular–regulated kinase (ERK), cell proliferation, type I collagen gene expression, and accumulation in HSC culture media were evaluated by Western blot, immunohistochemistry for bromodeoxyuridine (BrdU), Northern blot, and enzyme–linked immunosorbent assay, respectively. Insulin and IGF–1 receptors were detected in HSC in vitro and in liver sections from patients with chronic active hepatitis. Insulin and IGF–1 induced 70–kd S6 kinase phosphorylation in HSC, whereas IGF–1 only induced ERK phosphorylation. Insulin and IGF–1 stimulated HSC proliferation in a dose–dependent fashion, with IGF–1 being four to five times more potent than insulin. Cell exposure to specific inhibitors showed that both phosphatidylinositol 3–kinase (PI3–K) and ERK are involved in IGF–1-induced mitogenesis, whereas insulin stimulated mitogenesis through a PI3–K-dependent ERK–independent pathway. IGF–1 increased type I collagen gene expression and accumulation in HSC culture media through a PI3–K- and ERK–dependent mechanism. In conclusion, insulin and IGF–1, which stimulate HSC mitogenesis and collagen synthesis, may act in concert to promote liver fibrosis in vivo by a differential activation of PI3–K- and ERK1–dependent pathways.
1 March 1998 in Hepatology
Oxidative stress is associated with liver fibrosis and with hepatic stellate cell (HSC) activationin vivo. However, it remains controversial whether oxidative stress contributes to HSC activation either directly or through a paracrine stimulation by damaged hepatocytes. A medium containing products released from cells undergoing oxidative stress was obtained after incubation of hepatocytes with (HCM/Fe) or without (HCM) 0.1 mmol/L ferric nitrilotriacetate complex (FeNTA). Exposure of HSC to HCM/Fe for 24 hours significantly increased the number of proliferating HSC compared with HCM and to controls at all dilutions tested. The simultaneous coincubation of HSC with HCM/Fe and desferrioxamine (50 μmol/L) did not reduce the observed increase in cell proliferation, thus excluding a role for eventually contaminating iron in HCM/Fe. HCM/Fe induced also a significant increase in collagen type I accumulation in HSC culture media. To study the cellular mechanism underlying HCM/Fe effects, we evaluated the activity of the Na+/H+exchanger, which plays a role in regulating HSC proliferation. The incubation of HSC for 24 hours with HCM/Fe significantly increased baseline intracellular pH (pHi) and Na+/H+exchanger activity, indicating a plausible role of this antiport in mediating cell response. In conclusion, hepatocytes undergoing oxidative stress release factors which are fibrogenic for HSC, thereby, confirming what has been only hypothesizedin vivo. In addition, HSC proliferation is associated with changes in the Na+/H+exchanger activity, thus providing a useful target for the evaluation of inhibitors of this pathway for the treatment of hepatic fibrosis.
1 July 1995 in Gastroenterology
1 November 2002 in Journal of Hepatology
4 February 2013 in Rheumatology
Objectives. SSc is a clinically heterogeneous and generalized disease, characterized by thickness of the connective tissue of the skin and internal organs, such as the digestive tract, impairing gastrointestinal (GI) motility. Our aim is to evaluate retrospectively abnormalities of oesophageal motility, gastric emptying, oro-cecal transit time (OCTT) and small intestine bacterial overgrowth (SIBO) in a large cohort of SSc patients. Methods. Ninety-nine SSc patients were included in the study. Forty-two patients underwent oesophageal conventional manometry, 45 performed a [13C]octanoic acid breath test to measure gastric emptying time and all 99 patients performed a lactulose breath test in order to evaluate OCTT and SIBO. Data were compared with healthy controls. Results. In SSc patients, median lower oesophageal sphincter (LOS) pressure [14 mmHg (25th–75th; 8–19) vs 24 mmHg (19–28); P < 0.01] and median wave amplitude [30 mmHg (16–70) vs 72 mmHg (48–96); P < 0.01] were lower than in controls. Oesophageal involvement, defined as reduced LOS pressure and ineffective oesophageal motility pattern, was encountered in 70% of SSc patients. A delayed gastric emptying time was present in 38% of SSc patients: mean t½ was 141 ± 79 min vs 90 ± 40 min of controls (P < 0.01). Also, OCTT was significantly delayed in SSc: median OCTT was 160 min (25th–75th; 135–180) vs 105 min (25th–75th; 90–135) of controls (P < 0.01). SIBO was observed in 46% of SSc compared with 5% of controls (P < 0.01). Conclusion. GI involvement is very frequent in SSc patients. Oesophagus and small bowel are more frequently impaired, whereas delayed gastric emptying is less common.